Schedule D
The selling from Fresnius is mostly over.
The bulk of the planned reduction is complete, and the remaining amount under the 10b5-1 plan is relatively small. Selling could continue in limited amounts through late October 2026
August 10, 2026: 197,500 shares at a weighted average of $0.7249 per share (proceeds $143,167.75)
August 11, 2026: 220,000 shares at a weighted average of $0.7213 per share (proceeds $158,686.00)
August 12, 2026: 680,000 shares at a weighted average of $0.6389 per share (proceeds $434,452.00)
August 13, 2026: 1,300,000 shares at a weighted average of $0.5973 per share (proceeds $776,490.00)
August 14, 2026: 1,300,000 shares at a weighted average of $0.5585 per share (proceeds $726,050.00)
August 17, 2026: 1,012,000 shares at a weighted average of $0.5547 per share (proceeds $541,104.83)
In Amendment No. 11, they reported selling a total of 4,709,500 shares between August 10 and August 17, 2026. That leaves roughly 290,500 shares still authorized under the plan.